Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature

Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature

At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first...

Full description

Bibliographic Details
Main Authors: Silvia Bloise, Alessia Marcellino, Vanessa Martucci, Mariateresa Sanseviero, Alessia Testa, Emanuela Del Giudice, Mattia Spatuzzo, Daniel Sermoneta, Flavia Ventriglia, Riccardo Lubrano
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Children
Subjects:
children
vaccine
SARS-CoV-2
adverse event
lymphadenopathy
Online Access:https://www.mdpi.com/2227-9067/9/7/993

Internet

https://www.mdpi.com/2227-9067/9/7/993

Similar Items